Friday 23 February 2018
Contact US    |    Archive
cnbc.com
10 days ago

Novartis gains US approval for delayed multiple sclerosis drug

Novartis s Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis patients.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Novartis

 | 

gains

 | 

approval

 | 

for

 | 

delayed

 | 

multiple

 | 

sclerosis

 | 

drug

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA